Iressa is only one in a slew of drugs in AstraZeneca's brimming pipeline (see time line).
One exception is a dual cancer drug trial that Merck and AstraZeneca announced last year.
"This is a growing epidemic, " says Dr. Hamish Cameron, a vice president at AstraZeneca.
Aromatase inhibitors like AstraZeneca (nyse: AZN)'s tamoxifen were revolutionary in the treatment of breast cancer.
AstraZeneca and Bristol-Myers, after all, had good runs on these drugs--making billions and billions of dollars.
AstraZeneca challenged Andrx's version of Prilosec by saying that the generic drug wasn't really equivalent.
Sensing a breakthrough, AstraZeneca gambled in 2000 and began both kinds of trials at once.
Drug giants including Roche, Pfizer, and AstraZeneca have taken their own steps toward embracing stem-cell-based research.
FORBES: Stem Cell Innovator James Thomson Says Geron Blazed Trail For Others To Follow
So far, AstraZeneca has a bad record of bringing innovative new drugs to market.
"We know them from the cradle, " says Brent Vose, the head of oncology at AstraZeneca.
AstraZeneca settled a lawsuit that claimed Actavis violated the patent on its best-selling Crestor cholesterol pill.
FORBES: AstraZeneca & A Pay-To-Delay Deal The FTC Would Not Like
Every day that generics stay off the market, AstraZeneca gets millions of dollars in revenue.
Andrx accused AstraZeneca of trying to convince the FDA not to approve Andrx's generic Prilosec.
AstraZeneca used both techniques to tout its cholesterol drug Crestor as a potent artery unclogger.
AstraZeneca and rivals on the EGF front lacked this kind of detailed patient-targeting data.
Analysts pointed to big drug firms like Pfizer, GlaxoSmithKline, and AstraZeneca as potential bidders.
AstraZeneca PLC (AZN) : I may have saved the best for last in this London-based drugmaker.
But AstraZeneca is saying that it thinks Brilinta can be a multi-billion dollar product.
FORBES: Can Pascal Soriot Turn Around AstraZeneca? It May Come Down To One Drug
It is almost as if Myriad were a tapeworm eating part of AstraZeneca's market.
AstraZeneca's cholesterol drug has just been through a giant, 18, 000-patient study and the results are dramatic.
But in one small trial the AstraZeneca drug didn't much help 90% of the cancer patients.
AstraZeneca itself is building an arsenal of anti-cancer pills known as tyrosine kinase inhibitors.
Eli Lilly ( LLY - news - people ) and Seroquel from AstraZeneca.
The data from AstraZeneca's next study is expected in the first half of next year.
Dapagliflozin was developed by Bristol-Myers, but marketing rights were shared with AstraZeneca in a licensing deal.
Crestor, from AstraZeneca (nyse: AZN - news - people ) is another option.
Further evidence of emerging markets' potential comes from the experience of Britain's AstraZeneca in China.
ECONOMIST: Big drugmakers�� love affair with America is coming to an end
AstraZeneca's blockbuster cholesterol pill Crestor was originally maligned over kidney worries but has since been cleared.
"This is big, " AstraZeneca Chief Executive Sir Tom McKillop said of the compounds recently.
As a result, AstraZeneca has become the largest pharmaceutical multinational in Chinese prescription drugs.
应用推荐